Bristol Myers Earnings Estimate

BMY Stock

USD 59.14 0.38 0.65%

The next projected EPS of Bristol Myers is estimated to be 0.229325 with future projections ranging from a low of 0.180125 to a high of 0.2625. Bristol Myers' most recent 12-month trailing earnings per share (EPS TTM) is at -3.58. Please be aware that the consensus of earnings estimates for Bristol Myers Squibb is based on EPS before non-recurring items and includes expenses related to employee stock options.

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Bristol Myers is projected to generate 0.229325 in earnings per share on the 31st of December 2024. Bristol Myers earnings estimates show analyst consensus about projected Bristol Myers Squibb EPS (Earning Per Share). It derives the highest and the lowest estimates based on Bristol Myers' historical volatility. Many public companies, such as Bristol Myers, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Bristol Myers Revenue Breakdown by Earning Segment

By analyzing Bristol Myers' earnings estimates, investors can diagnose different trends across Bristol Myers' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Bristol Myers' Gross Profit is fairly stable compared to the past year. Pretax Profit Margin is likely to rise to 0.23 in 2025, whereas Operating Profit Margin is likely to drop 0.25 in 2025.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Bristol Myers Earnings Estimation Breakdown

The calculation of Bristol Myers' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Bristol Myers is estimated to be 0.229325 with the future projection ranging from a low of 0.180125 to a high of 0.2625. Please be aware that this consensus of annual earnings estimates for Bristol Myers Squibb is based on EPS before non-recurring items and includes expenses related to employee stock options.

Last Reported EPS

1.8

0.18

Lowest

Expected EPS

0.229325

0.26

Highest

Bristol Myers Earnings Projection Consensus

Suppose the current estimates of Bristol Myers' value are higher than the current market price of the Bristol Myers stock. In this case, investors may conclude that Bristol Myers is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Bristol Myers' stock will quickly adjusts to the new information provided by the consensus estimate.

Number of Analysts	Historical Accuracy	Last Reported EPS		Estimated EPS for 31st of December 2024	Current EPS (TTM)
26	89.57%	1.8		0.229325	-3.58

Bristol Myers Earnings History

Earnings estimate consensus by Bristol Myers Squibb analysts from Wall Street is used by the market to judge Bristol Myers' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Bristol Myers' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Bristol Myers Quarterly Gross Profit

8.94 Billion

At this time, Bristol Myers' Retained Earnings Total Equity is fairly stable compared to the past year. Price Earnings Ratio is likely to rise to 19.89 in 2025, whereas Retained Earnings are likely to drop slightly above 22 B in 2025. Net Income Applicable To Common Shares is likely to rise to about 6 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.6 B in 2025.

Hype

Prediction

Low	Estimated	High
56.88	58.84	60.80

Details

Intrinsic

Valuation

Low	Real	High
57.53	59.49	61.45

Details

Naive

Forecast

Low	Next	High
57.88	59.84	61.80

Details

26 Analysts

Consensus

Low	Target	High
55.52	61.01	67.72

Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Bristol assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Bristol Myers. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Bristol Myers' stock price in the short term.

Bristol Myers Earnings per Share Projection vs Actual

Actual Earning per Share of Bristol Myers refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Bristol Myers Squibb predict the company's earnings will be in the future. The higher the earnings per share of Bristol Myers, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Bristol Myers Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Bristol Myers, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Bristol Myers should always be considered in relation to other companies to make a more educated investment decision.

Bristol Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Bristol Myers' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2024-10-31	2024-09-30	1.49	1.8	0.31	20
2024-07-26	2024-06-30	1.63	2.07	0.44	26
2024-04-25	2024-03-31	-4.14	-4.4	-0.26	6
2024-02-02	2023-12-31	1.43	1.59	0.16	11
2023-10-26	2023-09-30	1.76	2.0	0.24	13
2023-07-27	2023-06-30	1.98	1.75	-0.23	11
2023-04-27	2023-03-31	1.97	2.05	0.08	4
2023-02-02	2022-12-31	1.72	1.82	0.1	5
2022-10-25	2022-09-30	1.83	1.99	0.16	8
2022-07-27	2022-06-30	1.79	1.93	0.14	7
2022-04-29	2022-03-31	1.91	2.06	0.15	7
2022-02-04	2021-12-31	1.8	1.83	0.03	1
2021-10-27	2021-09-30	1.92	2.0	0.08	4
2021-07-28	2021-06-30	1.89	1.93	0.04	2
2021-04-29	2021-03-31	1.82	1.74	-0.08	4
2021-02-04	2020-12-31	1.42	1.46	0.04	2
2020-11-05	2020-09-30	1.49	1.63	0.14	9
2020-08-06	2020-06-30	1.48	1.63	0.15	10
2020-05-07	2020-03-31	1.49	1.72	0.23	15
2020-02-06	2019-12-31	0.88	1.22	0.34	38
2019-10-31	2019-09-30	1.07	1.17	0.1	9
2019-07-25	2019-06-30	1.07	1.18	0.11	10
2019-04-25	2019-03-31	1.09	1.1	0.01	0
2019-01-24	2018-12-31	0.85	0.94	0.09	10
2018-10-25	2018-09-30	0.91	1.09	0.18	19
2018-07-26	2018-06-30	0.87	1.01	0.14	16
2018-04-26	2018-03-31	0.85	0.94	0.09	10
2018-02-05	2017-12-31	0.67	0.68	0.01	1
2017-10-26	2017-09-30	0.77	0.75	-0.02	2
2017-07-27	2017-06-30	0.74	0.74	0.0	0
2017-04-27	2017-03-31	0.74	0.84	0.1	13
2017-01-26	2016-12-31	0.67	0.63	-0.04	5
2016-10-27	2016-09-30	0.65	0.77	0.12	18
2016-07-28	2016-06-30	0.67	0.69	0.02	2
2016-04-28	2016-03-31	0.65	0.74	0.09	13
2016-01-28	2015-12-31	0.28	0.38	0.1	35
2015-10-27	2015-09-30	0.35	0.39	0.04	11
2015-07-23	2015-06-30	0.36	0.53	0.17	47
2015-04-28	2015-03-31	0.51	0.71	0.2	39
2015-01-27	2014-12-31	0.41	0.46	0.05	12
2014-10-24	2014-09-30	0.42	0.45	0.03	7
2014-07-24	2014-06-30	0.44	0.48	0.04	9
2014-04-29	2014-03-31	0.43	0.46	0.03	6
2014-01-24	2013-12-31	0.43	0.51	0.08	18
2013-10-23	2013-09-30	0.44	0.46	0.02	4
2013-07-25	2013-06-30	0.44	0.44	0.0	0
2013-04-25	2013-03-31	0.41	0.41	0.0	0
2013-01-24	2012-12-31	0.43	0.47	0.04	9
2012-10-24	2012-09-30	0.42	0.41	-0.01	2
2012-07-25	2012-06-30	0.48	0.48	0.0	0
2012-04-26	2012-03-31	0.63	0.64	0.01	1
2012-01-26	2011-12-31	0.55	0.53	-0.02	3
2011-10-27	2011-09-30	0.58	0.61	0.03	5
2011-07-28	2011-06-30	0.55	0.56	0.01	1
2011-04-28	2011-03-31	0.53	0.58	0.05	9
2011-01-27	2010-12-31	0.48	0.47	-0.01	2
2010-10-26	2010-09-30	0.53	0.59	0.06	11
2010-07-22	2010-06-30	0.53	0.54	0.01	1
2010-04-29	2010-03-31	0.51	0.56	0.05	9
2010-01-28	2009-12-31	0.41	0.47	0.06	14
2009-10-22	2009-09-30	0.51	0.52	0.01	1
2009-07-23	2009-06-30	0.47	0.56	0.09	19
2009-04-28	2009-03-31	0.47	0.48	0.01	2
2009-01-27	2008-12-31	0.41	0.46	0.05	12
2008-10-23	2008-09-30	0.42	0.46	0.04	9
2008-07-24	2008-06-30	0.4	0.43	0.03	7
2008-04-24	2008-03-31	0.41	0.42	0.01	2
2008-01-31	2007-12-31	0.34	0.35	0.01	2
2007-10-25	2007-09-30	0.37	0.38	0.01	2
2007-07-26	2007-06-30	0.36	0.37	0.01	2
2007-04-26	2007-03-31	0.23	0.38	0.15	65
2007-01-25	2006-12-31	0.16	0.19	0.03	18
2006-10-26	2006-09-30	0.2	0.22	0.02	10
2006-07-27	2006-06-30	0.32	0.35	0.03	9
2006-04-27	2006-03-31	0.32	0.32	0.0	0
2006-01-25	2005-12-31	0.28	0.31	0.03	10
2005-10-28	2005-09-30	0.33	0.31	-0.02	6
2005-07-28	2005-06-30	0.36	0.47	0.11	30
2005-04-28	2005-03-31	0.34	0.34	0.0	0
2005-01-27	2004-12-31	0.33	0.39	0.06	18
2004-10-29	2004-09-30	0.39	0.44	0.05	12
2004-07-29	2004-06-30	0.39	0.46	0.07	17
2004-04-28	2004-03-31	0.39	0.41	0.02	5
2004-01-29	2003-12-31	0.39	0.37	-0.02	5
2003-10-23	2003-09-30	0.41	0.47	0.06	14
2003-07-24	2003-06-30	0.38	0.45	0.07	18
2003-04-29	2003-03-31	0.38	0.39	0.01	2
2003-03-10	2002-12-31	0.27	0.31	0.04	14
2002-10-24	2002-09-30	0.26	0.26	0.0	0
2002-07-23	2002-06-30	0.26	0.23	-0.03	11
2002-04-25	2002-03-31	0.43	0.45	0.02	4
2002-01-24	2001-12-31	0.59	0.59	0.0	0
2001-10-23	2001-09-30	0.63	0.63	0.0	0
2001-07-25	2001-06-30	0.53	0.56	0.03	5
2001-04-25	2001-03-31	0.61	0.63	0.02	3
2001-01-24	2000-12-31	0.55	0.56	0.01	1
2000-10-19	2000-09-30	0.58	0.59	0.01	1
2000-07-20	2000-06-30	0.51	0.51	0.0	0
2000-04-20	2000-03-31	0.57	0.58	0.01	1
2000-01-24	1999-12-31	0.49	0.49	0.0	0
1999-10-19	1999-09-30	0.51	0.51	0.0	0
1999-07-21	1999-06-30	0.45	0.45	0.0	0
1999-04-21	1999-03-31	0.49	0.5	0.01	2
1999-01-20	1998-12-31	0.43	0.43	0.0	0
1998-10-20	1998-09-30	0.45	0.45	0.0	0
1998-07-21	1998-06-30	0.39	0.4	0.01	2
1998-04-21	1998-03-31	0.43	0.43	0.0	0
1998-01-22	1997-12-31	0.38	0.38	0.0	0
1997-10-21	1997-09-30	0.4	0.41	0.01	2
1997-07-22	1997-06-30	0.35	0.35	0.0	0
1997-04-22	1997-03-31	0.38	0.38	0.0	0
1997-01-22	1996-12-31	0.34	0.34	0.0	0
1996-10-22	1996-09-30	0.35	0.36	0.01	2
1996-07-22	1996-06-30	0.31	0.31	0.0	0
1996-04-23	1996-03-31	0.33	0.34	0.01	3

About Bristol Myers Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Bristol Myers earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Bristol Myers estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Bristol Myers fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.

	Last Reported	Projected for Next Year
Retained Earnings	33.1 B	22 B
Retained Earnings Total Equity	23 B	24.5 B
Earnings Yield	0.09	0.05
Price Earnings Ratio	11.91	19.89
Price Earnings To Growth Ratio	0.39	0.41

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bristol Myers Earnings Estimate

Bristol Myers Revenue Breakdown by Earning Segment

Bristol Myers Earnings Estimation Breakdown

Bristol Myers Earnings Projection Consensus

Bristol Myers Earnings History

Bristol Myers Quarterly Gross Profit

8.94 Billion

Bristol Myers Earnings per Share Projection vs Actual

Bristol Myers Estimated Months Earnings per Share

Bristol Quarterly Analyst Estimates and Surprise Metrics

About Bristol Myers Earnings Estimate

Also Currently Popular

Additional Tools for Bristol Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY